Systemic therapy in non-conventional cancers of the larynx

Laryngeal cancer (LC) is a significantly debilitating disease and one of the most challenging malignancies to treat. LC represents 0.8% of all new cancers in the United States. In 2014, there were an estimated 99 914 people living with LC, with about 13 360 cases diagnosed in 2017 [1]. While most (90 –95%) have conventional squamous cell carcinomas (SCC), the remaining cases are either a variant of SCC or another histology managed differently compared to conventional SCC [2]. Several of these tumor types are more often found in non-laryngeal sites and as a result, treatment in the larynx is of ten modeled after treatment at these sites
Source: Oral Oncology - Category: Cancer & Oncology Authors: Tags: Review Source Type: research